A decrease of HLA-DR expression was observed in pDCs and CD16+ monocytes in both MM and its precursor stages (Fig. 2d), indicating that a decrease of myeloid cell antigen presentation function begins early in the MGUS stage. The gene discussed is FCGR3A; the disease is Miyoshi myopathy.